Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis

Hua Ching Chang, Duen Yi Huang, Mai Szu Wu, Ching Liang Chu, Shiang Jong Tzeng, Wan Wan Lin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Erythropoietin (EPO) and GM-CSF are involved in erythropoiesis, while TGF-β inhibits proliferation but potentiates differentiation of erythroblasts. Since Syk inhibitor may induce anemia side effect in clinic, here we investigated the role of Syk in the biological actions of EPO and GM-CSF in erythropoiesis. In human erythroleukemia cell line TF-1, Syk inhibitor R406 exerts an enhancement effect with TGF-β to decrease cell viability, either in the absence or presence of EPO or GM-CSF. Such effect of R406 results from the reduced cell cycle progression and increased cell apoptosis. Notably, unlike Syk, Src family kinases are not involved in the viability control of TF-1 cells. Signaling studies showed that Syk is required for STAT5 and ERK activation induced by EPO, and Akt and ERK activation induced by GM-CSF. Nevertheless, R406 does not change the Smad2/3 signal caused by TGF-β, and TGF-β neither affects above signal pathways of EPO and GM-CSF. Of note, Syk is constitutively associated with EPOR in plasma membrane and can bind to STAT5 at active status upon EPO stimulation. Furthermore, EPO-induced hemoglobin γ expression was reduced by R406. In BFU-E and CFU-E colony formation assays in Syk-deficient erythroid progenitor cells, we confirmed the essential role of Syk in erythropoiesis mediated by EPO. Taken together, Syk is a novel upstream signaling molecule of EPOR, and contributes to erythroblast proliferation, survival and differentiation.

Original languageEnglish
Pages (from-to)687-696
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1864
Issue number4
DOIs
Publication statusPublished - Apr 1 2017

Fingerprint

Erythropoiesis
Granulocyte-Macrophage Colony-Stimulating Factor
Erythropoietin
Erythroid Precursor Cells
Erythroblasts
Leukemia, Erythroblastic, Acute
src-Family Kinases
Syk Kinase
Anemia
Signal Transduction
Cell Survival
Cell Cycle
Hemoglobins
Cell Membrane
Apoptosis
Cell Line
Survival

Keywords

  • EPO
  • Erythropoiesis
  • GM-CSF
  • Hemoglobin
  • Syk
  • TGF-β

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis. / Chang, Hua Ching; Huang, Duen Yi; Wu, Mai Szu; Chu, Ching Liang; Tzeng, Shiang Jong; Lin, Wan Wan.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1864, No. 4, 01.04.2017, p. 687-696.

Research output: Contribution to journalArticle

Chang, Hua Ching ; Huang, Duen Yi ; Wu, Mai Szu ; Chu, Ching Liang ; Tzeng, Shiang Jong ; Lin, Wan Wan. / Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis. In: Biochimica et Biophysica Acta - Molecular Cell Research. 2017 ; Vol. 1864, No. 4. pp. 687-696.
@article{350c1b135a9a4500b629a598abc6648c,
title = "Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis",
abstract = "Erythropoietin (EPO) and GM-CSF are involved in erythropoiesis, while TGF-β inhibits proliferation but potentiates differentiation of erythroblasts. Since Syk inhibitor may induce anemia side effect in clinic, here we investigated the role of Syk in the biological actions of EPO and GM-CSF in erythropoiesis. In human erythroleukemia cell line TF-1, Syk inhibitor R406 exerts an enhancement effect with TGF-β to decrease cell viability, either in the absence or presence of EPO or GM-CSF. Such effect of R406 results from the reduced cell cycle progression and increased cell apoptosis. Notably, unlike Syk, Src family kinases are not involved in the viability control of TF-1 cells. Signaling studies showed that Syk is required for STAT5 and ERK activation induced by EPO, and Akt and ERK activation induced by GM-CSF. Nevertheless, R406 does not change the Smad2/3 signal caused by TGF-β, and TGF-β neither affects above signal pathways of EPO and GM-CSF. Of note, Syk is constitutively associated with EPOR in plasma membrane and can bind to STAT5 at active status upon EPO stimulation. Furthermore, EPO-induced hemoglobin γ expression was reduced by R406. In BFU-E and CFU-E colony formation assays in Syk-deficient erythroid progenitor cells, we confirmed the essential role of Syk in erythropoiesis mediated by EPO. Taken together, Syk is a novel upstream signaling molecule of EPOR, and contributes to erythroblast proliferation, survival and differentiation.",
keywords = "EPO, Erythropoiesis, GM-CSF, Hemoglobin, Syk, TGF-β",
author = "Chang, {Hua Ching} and Huang, {Duen Yi} and Wu, {Mai Szu} and Chu, {Ching Liang} and Tzeng, {Shiang Jong} and Lin, {Wan Wan}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.bbamcr.2017.01.014",
language = "English",
volume = "1864",
pages = "687--696",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis

AU - Chang, Hua Ching

AU - Huang, Duen Yi

AU - Wu, Mai Szu

AU - Chu, Ching Liang

AU - Tzeng, Shiang Jong

AU - Lin, Wan Wan

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Erythropoietin (EPO) and GM-CSF are involved in erythropoiesis, while TGF-β inhibits proliferation but potentiates differentiation of erythroblasts. Since Syk inhibitor may induce anemia side effect in clinic, here we investigated the role of Syk in the biological actions of EPO and GM-CSF in erythropoiesis. In human erythroleukemia cell line TF-1, Syk inhibitor R406 exerts an enhancement effect with TGF-β to decrease cell viability, either in the absence or presence of EPO or GM-CSF. Such effect of R406 results from the reduced cell cycle progression and increased cell apoptosis. Notably, unlike Syk, Src family kinases are not involved in the viability control of TF-1 cells. Signaling studies showed that Syk is required for STAT5 and ERK activation induced by EPO, and Akt and ERK activation induced by GM-CSF. Nevertheless, R406 does not change the Smad2/3 signal caused by TGF-β, and TGF-β neither affects above signal pathways of EPO and GM-CSF. Of note, Syk is constitutively associated with EPOR in plasma membrane and can bind to STAT5 at active status upon EPO stimulation. Furthermore, EPO-induced hemoglobin γ expression was reduced by R406. In BFU-E and CFU-E colony formation assays in Syk-deficient erythroid progenitor cells, we confirmed the essential role of Syk in erythropoiesis mediated by EPO. Taken together, Syk is a novel upstream signaling molecule of EPOR, and contributes to erythroblast proliferation, survival and differentiation.

AB - Erythropoietin (EPO) and GM-CSF are involved in erythropoiesis, while TGF-β inhibits proliferation but potentiates differentiation of erythroblasts. Since Syk inhibitor may induce anemia side effect in clinic, here we investigated the role of Syk in the biological actions of EPO and GM-CSF in erythropoiesis. In human erythroleukemia cell line TF-1, Syk inhibitor R406 exerts an enhancement effect with TGF-β to decrease cell viability, either in the absence or presence of EPO or GM-CSF. Such effect of R406 results from the reduced cell cycle progression and increased cell apoptosis. Notably, unlike Syk, Src family kinases are not involved in the viability control of TF-1 cells. Signaling studies showed that Syk is required for STAT5 and ERK activation induced by EPO, and Akt and ERK activation induced by GM-CSF. Nevertheless, R406 does not change the Smad2/3 signal caused by TGF-β, and TGF-β neither affects above signal pathways of EPO and GM-CSF. Of note, Syk is constitutively associated with EPOR in plasma membrane and can bind to STAT5 at active status upon EPO stimulation. Furthermore, EPO-induced hemoglobin γ expression was reduced by R406. In BFU-E and CFU-E colony formation assays in Syk-deficient erythroid progenitor cells, we confirmed the essential role of Syk in erythropoiesis mediated by EPO. Taken together, Syk is a novel upstream signaling molecule of EPOR, and contributes to erythroblast proliferation, survival and differentiation.

KW - EPO

KW - Erythropoiesis

KW - GM-CSF

KW - Hemoglobin

KW - Syk

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=85011332664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011332664&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2017.01.014

DO - 10.1016/j.bbamcr.2017.01.014

M3 - Article

VL - 1864

SP - 687

EP - 696

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 4

ER -